Erythromycin Tablet, Delayed Release
Product Images NDC 69238-1471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 69238-1471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Erythromycin Delayed Release Tablets Usp 1)

FDA Label Image

10 (Erythromycin Delayed Release Tablets Usp 2)

10 (Erythromycin Delayed Release Tablets Usp 2)
This is a description of Erythromycin Delayed-Release Tablets, USP, with 260 mg of Erythromycin per tablet. The usual dosage is not provided, but it is recommended to refer to the package insert for full prescribing information. The tablets should be stored at room temperature, and tightly closed. They can be dispensed in a USP tight container. The tablets can be taken with or without food. Amneal Pharmaceuticals Pvt. Ltd. in India manufactures the product and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Mfg. Lic. No. G/28/1558 Rev. 08-2021-00 information is provided. Lot information is not available.*
FDA Label Image

10 (Erythromycin Delayed Release Tablets Usp 3)

10 (Erythromycin Delayed Release Tablets Usp 3)
Erythromycin is a medication that comes in delayed-release tablets with each tablet containing 250mg of the drug. The usual dosage and other prescribing information can be found in the package insert. It is recommended to store this medication between 20-25°C (68-77°F) with temperatures up to 30°C (86°F) being acceptable. The medication should be kept in a tightly closed container and dispensing should only be done if the seal in the bottle opening is not broken. The tablets can be administered without regard to meals. The medication is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
FDA Label Image

10 (Erythromycin Delayed Release Tablets Usp 4)

FDA Label Image

Erythromycin Delayed Release Tablets Usp 5

Erythromycin Delayed Release Tablets Usp 5
This is a description of a medication containing Erythromycin in delayed-release tablets. Each tablet contains 333 mg of Erythromycin. The usual dosage information is not available in the given text and the user is directed to the package for full prescribing information. The tablets should be stored at a temperature between 15°C and 30°C and kept in a USP tight container. The medication can be taken without regard to meals. The manufacturer of the medication is Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The manufacturing license number is G/28/1568 Rev. 03-2019-00.*
FDA Label Image

Erythromycin Delayed Release Tablets Usp 6

Erythromycin Delayed Release Tablets Usp 6
This is a description of a medication manufactured by Amneal Pharmaceuticals Pvt. Ltd. The medication contains 500mg of Erythromycin and is a delayed-release tablet. The text includes information on dosage instructions and storage requirements. It also provides details on the distributor, manufacturing license number, and NDC number.*
FDA Label Image

Erythromycin Delayed Release Tablets Usp 7

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.